Close to half of adults and one quarter of kids in the US regularly consume artificial sweeteners

Low-calorie sweeteners (LCSs) are often used in place of added sugars such as sucrose and high-fructose corn syrup in food and beverage products. While these artificial sweeteners offer less calories, their effects on weight management and long-term health are still under investigation. A new study in the Journal of the Academy of Nutrition and Dietetics reports that 41% of adults and 25% of children currently consume at least one LCS item on a regular basis. The researchers note that this represents a 200% increase for children and a 54% increase among adults compared to data reported in 1999-2000.

Are LCSs good for you? "Although LCSs were once believed to be physiologically inert, more recently their use has been suggested to influence metabolism," noted lead investigator Allison C. Sylvetsky, PhD, assistant professor of Exercise and Nutrition Sciences at the George Washington University Milken Institute School of Public Health. "Some studies have suggested a beneficial effect on weight loss, while others indicate that obesity risk increases with LCS use. Little is known about the impact of long-term consumption, particularly in children. Despite the perceived benefits of replacing caloric sugars with LCSs for weight loss, evidence for the effectiveness of this strategy is lacking and some studies suggest a link between LCSs and obesity, diabetes, and other health issues."

Using data from the 2009-2012 National Health Examination Survey (NHANES), investigators analyzed reported LCS consumption for both children and adults. Data showed that women were more likely to consume products containing LCSs and that consumption increased with body weight in adults, with people with obesity being more likely to consume LCSs than normal weight individuals. Adults with diabetes were more likely to consume LCSs compared to those without diabetes. The data also showed a relationship between LCS intake and race and income. People of non-Hispanic white race/ethnicity had higher rates of LCS consumption, as did those in higher income brackets.

Researchers noted that while parents are generally opposed to feeding their kids food or drinks containing LCSs based on prior research, they may not realize that many of the foods children bring home surprisingly contain artificial sweeteners. In addition, LCSs are now being incorporated into foods not traditionally thought of as high in sugar like yogurt, milk substitutes, breads, cereals, condiments, and drinks.

"We have previously reported that most parents have negative attitudes toward LCS consumption by their children, yet often do not recognize the presence of LCSs in foods and beverages that they purchase for their families," explained Dr. Sylvetsky. "This study raised the possibility that parents may preferentially select products with nutrient content claims such as 'no sugar added' or 'light' in an effort to provide healthier options to their children, without realizing that these sugar-modified products often contain LCSs. The presence of LCSs in foods commonly consumed by children, such as canned fruit, ice cream, flavored oatmeal, and snack bars, combined with strong marketing and promotion of products deemed to be healthier alternatives, may be driving LCS food intake in children."

The study also found that most reported LCS consumption occurs at home (71% and 72% among adults and children, respectively) and with meals (64% of adults, 62% of children). While LCSs still represented a relatively low overall proportion of total food intake, 44% of adults and 20% of children reported consuming multiple daily servings of LCSs. For 17% of LCS-consuming adults, that number was more than three times per day.

"While the effects of early life exposure to LCSs on taste preferences, weight management, and chronic disease prevention have not been well-studied in humans, compelling findings in animal models highlight the need to examine their potential health effects in humans," concluded Dr. Sylvetsky. "Given that a significant proportion of children and adults in the US consume LCSs, these findings emphasize the need for prospective, long-term, well-controlled studies to determine the chronic health effects, especially in children."

Allison C. Sylvetsky, Yichen Jin, Elena J. Clark, Jean A. Welsh, Kristina I. Rother, Sameera A. Talegawkar.
Consumption of Low-Calorie Sweeteners among Children and Adults in the United States.
Journal of the Academy of Nutrition and Dietetics, January 2017, doi: 10.1016/j.jand.2016.11.004.

Most Popular Now

Pfizer begins a Phase 1/2 study to evaluate respir…

Pfizer Inc. (NYSE:PFE) today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV i...

Eczema drug effective against severe asthma

Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe bett...

Most popular vitamin and mineral supplements provi…

The most commonly consumed vitamin and mineral supplements provide no consistent health benefit or harm, suggests a new study led by researchers at St. Michael's Hospital...

AstraZeneca heads to 2018 ASCO Annual Meeting with…

AstraZeneca and MedImmune, its global biologics research and development arm, head to the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, US...

Tiny particles could help fight brain cancer

Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median ...

Novartis data at ASCO and EHA reinforce company's …

Novartis will present data from across its oncology portfolio at the upcoming 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held June 1-5 ...

Spiolto® Respimat® enables greater physical activi…

Boehringer Ingelheim announced data which add to the growing body of evidence that show Spiolto® (tiotropium/olodaterol) Respimat® enables greater physical activity in pa...

Amgen Foundation and Harvard team up to offer free…

The Amgen Foundation and Harvard University today announced plans to launch a free online science education platform uniquely designed to level the playing field for aspi...

New approach to immunotherapy leads to complete re…

A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was...

Study demonstrates new treatment for severe asthma

Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering ...

The Pfizer Foundation announces $5 million in gran…

The Pfizer Foundation announced a new $5 million grant commitment to initiatives in low- and middle-income countries that provide family planning access and education for...

Study finds antioxidant-enriched vitamin reduces r…

Researchers at Children's Hospital Colorado (Children's Colorado) and the University of Colorado School of Medicine have found that taking a specially formulated antioxid...